Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
March 9, 2010
Patent Application Number
10583926
Date Filed
December 23, 2004
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present invention relates to the treatment of IL13 dependent neoplastic disorders comprising the administration of novel anti-IL13 antibodies, The invention also includes diagnosing such tumors or cancer using the antibodies of the present invention to detect overexpression of IL13 in the patient.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.